AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8998092
Drug: i.v. diltiazem
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. diltiazem and i.v. digoxin (combination)
Trial: 3539821
Drug: Doxycycline, 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline, 100 mg/day for 1 month
Trial: 30744517
Drug: Transcranial Pulsed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcranial Pulsed Electromagnetic Fields (active treatment)
Trial: 20523050
Drug: Rivastigmine 3-12
RxNorm normalized name: rivastigmine 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivastigmine 3-12 mg/day (capsules bid)
Trial: 11063155
Drug: Low SPGI
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low SPGI levels (< 25 microg/l) with diagnostic gastroscopy
Trial: 11063155
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with SPGI >= 50 microg/l
Trial: 11063155
Drug: Curative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curative treatment for early cancer or high-grade dysplasia
Trial: 2423800
Drug: Indoramin (50-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indoramin (50-100 mg/day)
Trial: 2423800
Drug: Pindolol (10-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol (10-20 mg/day)
Trial: 12723743
Drug: Ibuprofen lysine
RxNorm normalized name: Ibuprofen Lysine
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen lysine
Trial: 29667449
Drug: Ibuprofen liquid
RxNorm normalized name: ibuprofen Oral Liquid Product
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen liquid capsule
Trial: 26819724
Drug: Ibuprofen sodium
RxNorm normalized name: Ibuprofen sodium
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen sodium
Trial: 29667449
Drug: Ibuprofen acid
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen acid (reference)
Trial: 29667449
Drug: Ibuprofen salts
RxNorm normalized name: ibuprofen, sodium salt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen salts (overall)
Trial: 24420549
Drug: Intranasal angiotensin
RxNorm normalized name: Angiotensin 1-7
DrugBank: Angiotensin 1-7 (DB11720)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal angiotensin II (400 μg)
Trial: 20872550
Drug: No concomitant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No concomitant treatment (Control)
Trial: 19996984
Drug: Fospropofol 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fospropofol 2 mg/kg
Trial: 18194506
Drug: Fospropofol 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fospropofol 5 mg/kg
Trial: 19996984
Drug: Fospropofol 6.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fospropofol 6.5 mg/kg
Trial: 18194506
Drug: Fospropofol 8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fospropofol 8 mg/kg
Trial: 17189550
Drug: Antioxidant (AOX)
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant (AOX) treatment (800 IU of vitamin E, 500 mg of vitamin C, 10 mg of beta-carotene)
Trial: 17189550
Drug: Antioxidant (AOX)
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant (AOX) treatment
Trial: 29807257
Drug: Dilute vinegar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dilute vinegar lavage (20 mL of vinegar in 1 L saline) every second day during each estrus period (n=4)
Trial: 18569272
Drug: 3% diclofenac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3% diclofenac gel applied once daily
Trial: 18569272
Drug: 5% imiquimod
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% imiquimod cream applied three times a week for 12 weeks
Trial: 16048853
Drug: Integrated, multifaceted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated, multifaceted depression treatment model
Trial: 11831837
Drug: Antioxidant vitamin
RxNorm normalized name: antioxidant vitamins with minerals
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant vitamin cocktail (650 mg vitamin E, 250 mg vitamin C, 20 mg beta-carotene)
Trial: 7015172
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose subcutaneous heparin
Trial: 29914300
Drug: Prism adaptation
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prism adaptation with concurrent exposure
Trial: 30374818
Drug: 41.4 Gy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 41.4 Gy (low-dose)
Trial: 30374818
Drug: 50.4 Gy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50.4 Gy (high-dose)
Trial: 30374818
Drug: 45 Gy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 45 Gy (moderate-dose)
Trial: 26188541
Drug: Metformin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin treatment in type 2 diabetes patients
Trial: 21488751
Drug: Atomoxetine (ATX)
DrugBank: Atomoxetine (DB00289)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atomoxetine (ATX) fast: 7 days at 0.5 mg/kg, then 1.2 mg/kg
Trial: 21488751
Drug: Atomoxetine (ATX)
DrugBank: Atomoxetine (DB00289)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atomoxetine (ATX) slow: 7 days each at 0.5 and 0.8 mg/kg, then 1.2 mg/kg
Trial: 29845723
Drug: Imarikiren 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imarikiren 5 to 200 mg
Trial: 29845723
Drug: Imarikiren 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imarikiren 50 mg (Food Effect part)
Trial: 27025129
Drug: Remaxol at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remaxol at a dose of 800 mg/day for 7 days
Trial: 22884767
Drug: Exenatide QW
RxNorm normalized name: Exenatide
DrugBank: Exenatide (DB01276)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exenatide QW (2 mg)
Trial: 12207128
Drug: 0.05 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05 mg/kg piritramide intravenously (group A)
Trial: 1849152
Drug: Antacid (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antacid (30 mL Maalox) with 500 mg azithromycin
Trial: 1849152
Drug: Cimetidine (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (800 mg) 2 hours before 500 mg azithromycin
Trial: 1849152
Drug: Placebo before
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo before 500 mg azithromycin
Trial: 6639916
Drug: Fish-oil concentrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish-oil concentrate (MaxEPA), 10 g daily for 2 weeks
Trial: 6639916
Drug: Vegetable oil
RxNorm normalized name: Vegetable Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vegetable oil supplement, 10 g daily for 2 weeks
Trial: 25388552
Drug: Patient education
RxNorm normalized name: DIABETES PATIENT EDUCATION PACK
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient education combined with exercise therapy (supervised exercises 3 times/week for 3 months)
Trial: 25388552
Drug: Patient education
RxNorm normalized name: DIABETES PATIENT EDUCATION PACK
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient education combined with exercise therapy
Trial: 16911633
Drug: Nicotinamide (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotinamide (25 mg/kg daily)
Trial: 3330988
Drug: Nifedipine/diuretic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine/diuretic
Trial: 3330988
Drug: Placebo/diuretic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo/diuretic
Trial: 27608206
Drug: Fractional microneedling
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fractional microneedling radiofrequency (FMR) treatment on one side of the cheeks, two sessions with a 4-week interval.
Trial: 20300033
Drug: Method D
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Method D (5 minutes of jogging and a combination of static stretching and dynamic exercise)
Trial: 19378580
Drug: Infragluteal sciatic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infragluteal sciatic nerve block (Group 1) with 30 mL of 0.5% bupivacaine (S75/R25) with 1:200,000 epinephrine
Trial: 19378580
Drug: Parasacral sciatic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parasacral sciatic nerve block (Group 2) with 30 mL of 0.5% bupivacaine (S75/R25) with 1:200,000 epinephrine
Trial: 8630631
Drug: Meloxicam 7.5
RxNorm normalized name: meloxicam 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meloxicam 7.5 mg and Meloxicam 15 mg
Trial: 1465080
Drug: Low protein
RxNorm normalized name: Low protein mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low protein intake (0.8‐1.1 g/kg/day)
Trial: 23076450
Drug: Aliskiren/amlodipine combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren/amlodipine combination therapy
Trial: 19207891
Drug: Subantimicrobial dose
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subantimicrobial dose doxycycline (SDD) 20 mg b.i.d. + surgery
Trial: 17086096
Drug: Prednisone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (1 mg/kg/day with a maximum dose of 60 mg/day)
Trial: 31472039
Drug: High circulating
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High circulating dipeptidyl peptidase 3 (cDPP3) group (cDPP3 ≥59.1 ng/mL) at inclusion
Trial: 29600897
Drug: Intravenous esmolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous esmolol (β1‐adrenergic receptor antagonist)
Trial: 26613591
Drug: Glucose metabolism
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose metabolism and body composition measures
Trial: 18986282
Drug: Oral antibacterial
RxNorm normalized name: Dermoplast Antibacterial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antibacterial drugs
Trial: 18986282
Drug: Intravenously administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenously administered antibacterial drugs
Trial: 10390914
Drug: Low-dose acetylsalicylic
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose acetylsalicylic acid (ASA) (1.5 mg/kg)
Trial: 10390914
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (Sadamin, Partusisten, glucose i.v., amino acids i.v.)
Trial: 8686047
Drug: Treatment with
RxNorm normalized name: Campho-Phenique Cold Sore Treatment with Drying Action
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment with gold and penicillamine
Trial: 6286089
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with periodic reinductions
Trial: 8294223
Drug: Naltrexone 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone 25 mg/day for 4 weeks followed by 50 mg/day for 4 weeks
Trial: 3505536
Drug: Brand A
RxNorm normalized name: Select Brand Aspirin 325mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brand A salbutamol metered-dose inhaler (MDI)
Trial: 3505536
Drug: Brand B
RxNorm normalized name: Select Brand Bulk-Forming Laxative Powder for Suspension (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brand B salbutamol metered-dose inhaler (MDI)
Trial: 25054392
Drug: Tapentadol PR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapentadol PR (100 - 250 mg bid)
Trial: 25054392
Drug: Morphine CR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine CR (40 - 100 mg bid)
Trial: 25054392
Drug: Morphine CR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine CR
Trial: 16192367
Drug: Ibuprofen (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (400 mg qid for 2 days)
Trial: 16192367
Drug: Rofecoxib (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib (25 mg once a day for 5 days)
Trial: 8625171
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of 5-FU (1000 mg/m2, days 1-4) with bolus FA (200 mg/m2, days 1-4)
Trial: 8625171
Drug: Bolus 5-FU
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Bolus 5-FU (375 mg/m2, days 1-5) with bolus FA (200 mg/m2, days 1-5)
Trial: 2404768
Drug: Nimodipine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimodipine (30 mg q.i.d. orally for 14 days)
Trial: 29260401
Drug: Post-exercise protein
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-exercise protein supplementation made from cow's milk (13 g of proteins)
Trial: 16238896
Drug: IV metamizol
RxNorm normalized name: Metamizole
DrugBank: Metamizole (DB04817)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV metamizol 1 g
Trial: 12151921
Drug: Propofol at
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol at 600 ng/ml
Trial: 12151921
Drug: Propofol at
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol at 1000 ng/ml
Trial: 677431
Drug: Fentanyl (0.80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (0.80 mcg/kg body weight/10 min) and Flunitrazepam (1 mg)
Trial: 677431
Drug: Naloxone (0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (0.05 mg) administered postoperatively
Trial: 7104154
Drug: pindolol 10
RxNorm normalized name: pindolol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pindolol 10 mg three times daily for 4 weeks
Trial: 7104154
Drug: metoprolol 100
RxNorm normalized name: metoprolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metoprolol 100 mg three times daily for 4 weeks
Trial: 31049085
Drug: Intravenous ketorolac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ketorolac 0.9 mg/Kg
Trial: 31049085
Drug: Intravenous nalbuphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous nalbuphine 0.25 mg/Kg
Trial: 26327289
Drug: Local treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local treatment focusing on quadriceps strengthening, quadriceps stretching, and taping for fortnight 1, supplemented with individualized global treatment focusing on lower limb posture and movement patterns for fortnight 2, followed by ongoing self-management.
Trial: 27129006
Drug: Darunavir oral
RxNorm normalized name: darunavir Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darunavir oral suspension (100 mg/mL, 6 mL) with low-dose ritonavir (100 mg, days 1-5)
Trial: 27129006
Drug: Darunavir tablets
RxNorm normalized name: Darunavir Tablets
DrugBank: Darunavir (DB01264)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Darunavir tablets (600 mg, 2 x 300 mg) with low-dose ritonavir (100 mg, days 1-5)
Trial: 27129006
Drug: Darunavir oral
RxNorm normalized name: darunavir Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darunavir oral suspension (600 mg) with low-dose ritonavir (100 mg, days 1-9)
Trial: 20041911
Drug: Ocinaplon 90
RxNorm normalized name: Ocinaplon
DrugBank: Ocinaplon (DB06529)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ocinaplon 90 mg t.i.d.
Trial: 17670917
Drug: Lifestyle modification
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lifestyle modification and metformin
Trial: 15732092
Drug: BILN‐2061, 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BILN‐2061, 500 mg twice-daily for 2 days
Trial: 11874817
Drug: Nebulized budesonide
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Nebulized budesonide (2 mg every 6 h, n = 71)
Trial: 11874817
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone (30 mg every 12 h, n = 62)
Trial: 8860064
Drug: Nisoldipine 20
RxNorm normalized name: nisoldipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nisoldipine 20 mg once daily
Trial: 8522634
Drug: Nisoldipine 60
RxNorm normalized name: Nisoldipine
DrugBank: Nisoldipine (DB00401)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nisoldipine 60 mg once daily
Trial: 8522634
Drug: Nisoldipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nisoldipine (20 mg and 60 mg)
Trial: 31444972
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy ± bevacizumab
Trial: 20568428
Drug: Three-step acupuncture
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-step acupuncture combined with oral administration of Aspirin for six months
Trial: 20568428
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of Aspirin alone
Trial: 20568428
Drug: Three-step acupuncture
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-step acupuncture combined with oral administration of Aspirin
Trial: 14664898
Drug: Simvastatin 80
RxNorm normalized name: simvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 80 mg/day (n=16)
Trial: 14664898
Drug: Atorvastatin 40
RxNorm normalized name: atorvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 40 mg/day (n=16)
Trial: 29917215
Drug: Micronised dispersible
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronised dispersible ferric pyrophosphate plus alpha-lactalbumin (MDFP-AL), 30 mg of MDFP-AL per day for 30 days
Trial: 29917215
Drug: Ferrous gluconate
RxNorm normalized name: Ferrous Gluconate
DrugBank: Ferrous gluconate (DB14488)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous gluconate (FG), 80 mg of FG per day for 30 days
Trial: 27889710
Drug: IV maintenance
RxNorm normalized name: ReddyPort NIV Maintenance Kit KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV maintenance therapy with phenobarbitone
Trial: 18794651
Drug: Antipsychotic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipsychotic treatment (specifics not provided)
Trial: 1531464
Drug: Intranasal nafarelin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal nafarelin 200 micrograms two times a day
Trial: 1531464
Drug: Oral danazol
RxNorm normalized name: Danazol
DrugBank: Danazol (DB01406)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral danazol 200 mg three times a day
Trial: 24915052
Drug: Nifedipine GITS
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine GITS 30 mg plus Valsartan 80 mg (N30+V80)
Trial: 24915052
Drug: Nifedipine GITS
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine GITS 60 mg (N60)
Trial: 15579516
Drug: Valsartan 160
RxNorm normalized name: valsartan 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan 160 mg (V160)
Trial: 22168345
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g of alcohol per kilogram of body mass
Trial: 20224514
Drug: Concentration-controlled mycophenolate
RxNorm normalized name: mycophenolate
DrugBank: Mycophenolic acid (DB01024)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concentration-controlled mycophenolate mofetil (MMF) dosing based on mycophenolic acid (MPA) exposure
Trial: 20224514
Drug: Concentration-controlled mycophenolate
RxNorm normalized name: mycophenolate
DrugBank: Mycophenolic acid (DB01024)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concentration-controlled mycophenolate mofetil (MMF) dosing
Trial: 20224514
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (Concentration-controlled and Fixed-dose)
Trial: 1433451
Drug: Hepatitis B
RxNorm normalized name: HEPATITIS B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis B vaccine alone (3 doses at 0, 1, 2 months)
Trial: 1433451
Drug: Hepatitis B
RxNorm normalized name: HEPATITIS B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis B vaccine + HBIG (3 doses at 0, 1, 2 months)
Trial: 6228473
Drug: Hepatitis B
RxNorm normalized name: HEPATITIS B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis B vaccine alone
Trial: 1433451
Drug: Hepatitis B
RxNorm normalized name: HEPATITIS B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis B vaccine + HBIG
Trial: 28370973
Drug: 7 days
RxNorm normalized name: ZINGIBER OFFICINALE (GINGER) ROOT OIL 0.006 mg in 30 mg TOPICAL LIQUID [JAYSUING 7 Days Nail Fungus Treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7 days of antibiotic treatment according to bacteriogram sensitivity
Trial: 28370973
Drug: Observational group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Observational group (no treatment)
Trial: 27185197
Drug: Ofatumumab 1000
RxNorm normalized name: ofatumumab 1000 MG in 50 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofatumumab 1000 mg on days 1 and 8 of the first cycle and day 1 of the second and third cycles (O-ESHAP)
Trial: 24645632
Drug: Non-skin cancers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-skin cancers (oral, lung, colon, breast, prostate, thyroid, leukemia, lymphoma, central nervous system)
Trial: 3219315
Drug: Meals containing
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meals containing 220 g protein/kg dry weight
Trial: 23552127
Drug: Zofenopril 60
RxNorm normalized name: Zofenopril
DrugBank: Zofenopril (DB13166)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zofenopril 60 mg and ASA 100 mg
Trial: 23552127
Drug: Ramipril 10
RxNorm normalized name: ramipril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril 10 mg and ASA